The seroprevalence of passively collected samples from individuals with suspicious symptoms varied from 1.3% (2022) to 7.6% (2013); moreover, it showed a decreasing trend over the years ( Fig. 1 ).
← all excerpts
Visceral Leishmaniasis in Iran: An Update on Epidemiological Features from 2013 to 2022.
1
—
—